Evidence map›Paper›PMID 32712771›Full record

ArticleMedical oncology (Northwood, London, England)2020

Prospective evaluation of an anti-cancer drugs management programme in a dedicated oral therapy center (DICTO programme).

Elise Deluche, Tiffany Darbas, Kevin Bourcier, Loic Montangon, Geraldine Bayard, Evelyne Caille, Julie Querrioux, Chantal Suchaud, Sonia Zabaleta, Sabine Chaput and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Medical oncology (Northwood, London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Elise DelucheDepartment of Medical Oncology, University Hospital, Limoges, France. elise.deluche@chu-limoges.fr.ORCID http://orcid.org/0000-0001-8474-3116
Tiffany DarbasDepartment of Medical Oncology, University Hospital, Limoges, France.
Kevin BourcierDepartment of Medical Oncology, University Hospital, Limoges, France.
Loic MontangonRéseau Onco-Nouvelle-Aquitaine, Saint-Benoît, France.
Geraldine BayardDepartment of Medical Oncology, University Hospital, Limoges, France.
Evelyne CailleDepartment of Medical Oncology, University Hospital, Limoges, France.
Julie QuerriouxDepartment of Medical Oncology, University Hospital, Limoges, France.
Chantal SuchaudDepartment of Medical Oncology, University Hospital, Limoges, France.
Sonia ZabaletaDepartment of Medical Oncology, University Hospital, Limoges, France.
Sabine ChaputDepartment of Medical Oncology, University Hospital, Limoges, France.
Valerie Le Brun-LyDepartment of Medical Oncology, University Hospital, Limoges, France.
Julia PestreDepartment of Medical Oncology, University Hospital, Limoges, France.
Laurence VenatDepartment of Medical Oncology, University Hospital, Limoges, France.ORCID http://orcid.org/0000-0002-0716-2550
Frédéric ThuillierDepartment of Medical Oncology, University Hospital, Limoges, France.
Elodie NevadoDepartment of Pharmacy, University Hospital, Limoges, France.
Gaelle MaillanDepartment of Pharmacy, University Hospital, Limoges, France.
Jeremy JostDepartment of Pharmacy, University Hospital, Limoges, France.ORCID http://orcid.org/0000-0001-5543-3741
Sophie LeobonDepartment of Medical Oncology, University Hospital, Limoges, France.ORCID http://orcid.org/0000-0001-9283-4763
Nicole Tubiana-MathieuDepartment of Medical Oncology, University Hospital, Limoges, France.ORCID http://orcid.org/0000-0001-7849-3667
Sandrine Lavau-DenesDepartment of Medical Oncology, University Hospital, Limoges, France.
Université de Limoges · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral therapies have highly modified cancer patient management and changed hospital practises. We introduce a specific Oral Therapy Centre and retrospectively review information prospectively recorded by co-ordination nurses (CNs) (the DICTO programme). We describe the roles played by CNs in the management of oral cancer therapies at Limoges Dupuytren Hospital between May 2015 and June 2018. All cancers, irrespective of stage or whether oral general chemotherapy or targeted therapy was prescribed, are included. We followed up 287 patients of median age 67 years (range 26-89 years). Of these, 76% had metastases and 44% were on first-line therapy. The vast majority (88%) of their first CN contacts occurred just after physician consultation and lasted an average of 60 min. As part of follow-up, the CNs made 2719 calls (average 10 min) to patients to educate them and to verify compliance and drug tolerance. They also received 833 calls from patients (70%) or their relatives or health professionals (30%) seeking advice on management of side effects. In addition to the initial appointments, 1069 non-scheduled follow-up visits were made to assess side effects (49.2%). The CNs devoted 5 h to each patient over 3 months of treatment (i.e. 25 min/day) and, also organised scheduled hospitalisations in the department of oncology for 51% of patients. We show the interest and real-life work in a specific oral therapy centre within oncology department with the role of CNs to facilitate the global health care of the patients.

Indexed as

Administration, OralAdultAgedAged, 80 and overAntineoplastic AgentsFemaleHospitalizationHumansMaleMiddle AgedNeoplasm MetastasisNeoplasmsNurse's RolePatient ComplianceProspective StudiesRetrospective StudiesAntineoplastic AgentsCancerCo-ordinationMultidisciplinary managementOral therapies

Identifiers

PMID32712771
PMCPMC7382654
OpenAlexW3045108273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.